2-Hydroxybenzylamine (2-HOBA)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 2-Hydroxybenzylamine (2-HOBA), covering 2024-11-21 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) [Phase 2]